×
About 48,028 results

IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
https://clinicaltrials.gov/ct2/show/NCT05516797

Sep 30th, 2022 - The purpose of this three-month, randomized, controlled trial is to compare the difference in change in 14-day CGM-derived TIR (% time with glucose 70-180 mg/dL) from Baseline to 3-months Post-Dietary Change in participants with T2D who are assigned to use either BGM or CGM. The difference in mean blood ketone levels and additional glycemic endpoints will also be compared, and several explorato...

Diagnosing and Treating Low Blood Sugar Levels
https://clinicaltrials.gov/ct2/show/NCT00001276

Sep 30th, 2022 - The purpose of this protocol is to continue our studies of the evaluation and treatment of patients with fasting hypoglycemia due to diverse etiologies. Patients will be admitted to the Clinical Research Center under this protocol and undergo supervised fasting, dynamic tests of insulin secretion when appropriate, medically indicated imaging studies, and appropriate medical and surgical treatme...

Look AHEAD: Action for Health in Diabetes
https://clinicaltrials.gov/ct2/show/NCT00017953

Sep 30th, 2022 - Look AHEAD is examining, in overweight volunteers with type 2 diabetes, the long-term effects of an intensive lifestyle intervention program designed to achieve and maintain weight loss by decreased caloric intake and increased physical activity. This program will be compared to a control condition involving a program of diabetes support and education. The primary hypothesis is that the inciden...

The Effect of Aerobic Exercise on Genetic Molecules
https://clinicaltrials.gov/ct2/show/NCT04181853

Sep 30th, 2022 - Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise...

Closed-loop for People Living With Cystic Fibrosis Related Diabetes
https://clinicaltrials.gov/ct2/show/NCT05562492

Sep 30th, 2022 - Purpose of clinical trial: To determine if closed-loop can improve glucose control and health-related quality of life compared to standard insulin therapy with CGM in young people (≥16 years) and adults with Cystic Fibrosis related diabetes. Study objectives: The study objective is to compare closed-loop glucose control with standard insulin therapy with CGM in young people and adults with CF r...

CGMIS 48-hour Feasibility Study
https://clinicaltrials.gov/ct2/show/NCT05562206

Sep 30th, 2022 - This is a single center, single arm non-randomized study of 48-hour CGMIS wear duration incorporating two meal-challenge tests to explore the performance of a single insertion combined glucose-sensing insulin delivery cannula.

Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients
https://clinicaltrials.gov/ct2/show/NCT05562063

Sep 30th, 2022 - The clinical benefits of the dual Sodium-Glucose cotransporter (SGLT) 1 and 2-inhibition have recently been reported in two clinical trials. The SOLOIST reported the benefits of sotagliflozin in Type-2 Diabetes Mellitus (T2DM) patients hospitalized for worsening of Heart Failure (HF), while the SCORED involved T2DM patients with Chronic Kidney Disease (CKD). It is worth noting that not only did...

Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes
https://clinicaltrials.gov/ct2/show/NCT05560971

Sep 30th, 2022 - Specific aims of the study are as follows: 1) To test whether supplementation of POA, as compared to placebo, improves insulin sensitivity. 2) To test whether supplementation of POA, as compared to placebo, ameliorates hepatosteatosis and decreases whole-body fat mass, serum triglyceride, and LDL cholesterol. 3)To determine whether supplementation of POA, as compared to placebo, decreases plasm...

Effects of Peppermint Oil in Cardiometabolic Outcomes in Participants With Metabolic Syndrome
https://clinicaltrials.gov/ct2/show/NCT05561543

Sep 30th, 2022 - Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Previous non-randomized interventions have shown that oral...

T2DM Intensity Lifestyle Intervention
https://clinicaltrials.gov/ct2/show/NCT05561855

Sep 30th, 2022 - Diabetes mellitus is a chronic systemic metabolic disease caused by the long-term interaction of genetic factors and environmental factors. It is characterized by an increase in plasma glucose levels and is mainly due to metabolic disorders in glucose, fat, and protein caused by insufficient insulin secretion and/or dysfunction in the body, which affects normal physiological activities. As of 2...

Competition Induced Hyperglycemia in Athletes With Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT05561517

Sep 30th, 2022 - Design 12 athletes with T1D and 12 healthy athletes are included in a prospective experimental randomized, cross-over study. Screening visit Investigator Rakel Fuglsang Johansen will orally inform eligible athletes about the study at the screening visit at Steno Diabetes Center Aarhus. Individuals who have agreed to join the study (given oral and written informed consent), will have a short phy...

Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype Study
https://clinicaltrials.gov/ct2/show/NCT05548881

Sep 30th, 2022 - Study Description: This is a deep phenotype study of women who are determined to have 45,X mosaicism as a secondary genomic finding following cfDNA sequencing during pregnancy. Objectives: To define and describe a comprehensive phenotype of women with confirmed 45,X mosaicism initially found by cfDNA including cardiovascular, skeletal, metabolic, reproductive, audiometric, immunologic, and psyc...

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
https://clinicaltrials.gov/ct2/show/NCT05417425

Sep 30th, 2022 - The study will have three phases: screening, treatment and healing confirmation. The screening phase is to determine eligibility of subjects and chronicity of the diabetic foot ulcer and will include off-loading. The treatment phase begins with assessment to confirm continued eligibility and if met, subjects will be treated weekly with the Omeza combination therapy and standard of care to conti...

Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation
https://clinicaltrials.gov/ct2/show/NCT05404711

Sep 30th, 2022 - Youth-onset type 2 diabetes (T2D), an increasingly common and aggressive disease that disproportionately impacts racial and ethnic minorities, presents several diagnostic challenges. The rapid loss of glycemic control soon after T2D diagnosis makes early identification an important goal in pediatrics, and risk-based screening has been recommended for children for over two decades. However, the ...

Diabetes Companion App for Adults With Diabetes and Their Carers
https://clinicaltrials.gov/ct2/show/NCT05535842

Sep 30th, 2022 - Adopting a healthier lifestyle and disease self-management skills is critical to reducing the risk of diabetes-related complications. Internationally, and in Singapore, the majority of people with diabetes report not having received structured diabetes education, while others have the knowledge and fail to apply it in their daily lives. Key self-management behaviours recommended by the American...

The Link Between "Time In Range" Versus HbA1c and the Presence of Chronic COmplications in Type 1 Diabetes: a Longitudinal Study
https://clinicaltrials.gov/ct2/show/NCT05530369

Sep 30th, 2022 - Adult subjects (age ≥ 18 years) with T1D were consecutively recruited in three multicenter studies (RESCUE, FUTURE, ALERTT1 studies) organized between September 2014 and 19 November 2021. For the TIRCO study, only the data from patients recruited at the University Hospital of Antwerp were analyzed. Initially, the data from 498 patients were collected. Pregnant patients and patients with beta-ce...

GODART Pilot and Feasibility
https://clinicaltrials.gov/ct2/show/NCT05344859

Sep 30th, 2022 - Evidence-based guidelines for type 2 diabetes mellitus (T2DM) management aimed at glycemic control (reduced hemoglobin A1c) include a combination of diet, physical activity (PA), glucose monitoring, and medication adherences. However, the majority of individuals with T2DM are unable to follow these guidelines due to a lack of consistent health behavior counseling offered in the primary care set...

Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study
https://clinicaltrials.gov/ct2/show/NCT01817127

Sep 30th, 2022 - This study's objectives include: 1) develop a better understanding of the composition and structures of breast milk over the early stages of lactation with specific emphasis on the glycans and lipids; 2) how glycan diversity relates to maternal and infant gut microbiota with an emphasis on bifidobacteria species; 3)how milk composition and structure relate to maternal health and diet. These sam...

DISCOVER iCaReMe Global Registry
https://clinicaltrials.gov/ct2/show/NCT03549754

Sep 30th, 2022 - The registry intends to provide real world data on patient management and quality of care for patients with T2DM, heat failure and chronic kidney disease in clinical practice in many countries. To bridge this gap an observational voluntary registry is set up to capture real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 di...

Links Between Inflammation and Cardiometabolic Diseases
https://clinicaltrials.gov/ct2/show/NCT01934660

Sep 30th, 2022 - Over the past two decades, the number of subjects with cardiometabolic diseases (CMD) such as atherosclerotic cardiovascular disease (CVD), dyslipidemia, insulin resistance and diabetes have been rising. Characterizing these disease states reveals that inflammation is a common feature of CMD; however, mechanistic links between inflammation and these disease states in humans remain poorly unders...